Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/737207/000149315217005362/form10-q.htm
SEC Filings
737207 Annual Reports
10-K Annual Report April 2018
10-K Annual Report March 2017
10-K Annual Report March 2016
10-K Annual Report February 2015
10-K Annual Report August 2014
10-K Annual Report July 2014
10-K Annual Report October 2012
10-K Annual Report March 2011
10-K Annual Report March 2010
10-K Annual Report April 2009
10-K Annual Report April 2018
10-K Annual Report March 2017
10-K Annual Report March 2016
10-K Annual Report February 2015
10-K Annual Report August 2014
10-K Annual Report July 2014
10-K Annual Report October 2012
10-K Annual Report March 2011
10-K Annual Report March 2010
10-K Annual Report April 2009
737207 Quarterly Reports
737207 Corporate News
Bylaw Change
Financial Exhibit
Other Events October 2018
Ending Agreement
Event for Officers
Financial Exhibit
New Agreement
Other Events October 2018
Event for Officers
Financial Exhibit
New Agreement
Other Events September 2018
Bylaw Change
Financial Exhibit
New Agreement
Security Holders Change
Unregistered Sales July 2018
Event for Officers
Financial Exhibit
Other Events June 2018
Event for Officers
Financial Exhibit
New Agreement
Other Events June 2018
Financial Exhibit
New Agreement
Unregistered Sales May 2018
Event for Officers May 2018
Bylaw Change
Financial Exhibit
New Agreement
Security Holders Change
Unregistered Sales April 2018
Bylaw Change
Financial Exhibit
Other Events
Financial Exhibit
Other Events
October 2018
Ending Agreement
Event for Officers
Financial Exhibit
New Agreement
Other Events
Event for Officers
Financial Exhibit
New Agreement
Other Events
October 2018
Event for Officers
Financial Exhibit
New Agreement
Other Events
Financial Exhibit
New Agreement
Other Events
September 2018
Bylaw Change
Financial Exhibit
New Agreement
Security Holders Change
Unregistered Sales
Financial Exhibit
New Agreement
Security Holders Change
Unregistered Sales
July 2018
Event for Officers
Financial Exhibit
Other Events
Financial Exhibit
Other Events
June 2018
Event for Officers
Financial Exhibit
New Agreement
Other Events
Financial Exhibit
New Agreement
Other Events
June 2018
Financial Exhibit
New Agreement
Unregistered Sales
New Agreement
Unregistered Sales
May 2018
Event for Officers
May 2018
Bylaw Change
Financial Exhibit
New Agreement
Security Holders Change
Unregistered Sales
Financial Exhibit
New Agreement
Security Holders Change
Unregistered Sales
April 2018
Last10K.com | 10-Q Quarterly Report Mon May 15 2017
Document and Entity Information - shares | 3 Months Ended | |
|---|---|---|
Mar. 31, 2017 | May 15, 2017 | |
| Document And Entity Information | ||
| Entity Registrant Name | Marina Biotech, Inc. | |
| Entity Central Index Key | 0000737207 | |
| Document Type | 10-Q | |
| Document Period End Date | Mar. 31, 2017 | |
| Amendment Flag | false | |
| Current Fiscal Year End Date | --12-31 | |
| Entity Filer Category | Smaller Reporting Company | |
| Entity Common Stock, Shares Outstanding | 97,169,153 | |
| Trading Symbol | MRNA | |
| Document Fiscal Period Focus | Q1 | |
| Document Fiscal Year Focus | 2017 |
View differences made from one quarter to another to evaluate Adhera Therapeutics, Inc.'s financial trajectory
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Adhera Therapeutics, Inc..
Assess how Adhera Therapeutics, Inc.'s management team is paid from their Annual Proxy
Adhera Therapeutics, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:
- Voting Procedures
- Board Members
- Executive Team
- Salaries, Bonuses, Perks
- Peers / Competitors
SEC Filing Tools
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Document And Entity Information
Condensed Consolidated Balance Sheets (unaudited)
Condensed Consolidated Balance Sheets (unaudited) (parenthetical)
Condensed Consolidated Statements Of Cash Flows (unaudited)
Condensed Consolidated Statements Of Changes In Equity (capital Deficiency) (unaudited)
Condensed Consolidated Statements Of Operations (unaudited)
Commitments And Contingencies
Intangible Assets
Intangible Assets (details Narrative)
Intangible Assets (tables)
Intangible Assets - Schedule Of Intangible Assets (details)
Intellectual Property And Collaborative Agreements
Intellectual Property And Collaborative Agreements (details Narrative)
Nature Of Operations, Basis Of Presentation And Significant Accounting Policies
Nature Of Operations, Basis Of Presentation And Significant Accounting Policies (details Narrative)
Nature Of Operations, Basis Of Presentation And Significant Accounting Policies (policies)
Nature Of Operations, Basis Of Presentation And Significant Accounting Policies (tables)
Nature Of Operations, Basis Of Presentation And Significant Accounting Policies - Schedule Of Anti-dilutive Securities (details)
Nature Of Operations, Basis Of Presentation And Significant Accounting Policies - Schedule Of Fair Value Liability Of Price Adjustable Warrants Determined By Level 3 (details)
Nature Of Operations, Basis Of Presentation And Significant Accounting Policies - Schedule Of Liabilities Measured At Fair Value On A Recurring Basis (details)
Notes Payable
Notes Payable (details Narrative)
Organization And Business Operations - Schedule Estimate Of Fair Value Of Assets Acquired And Liabilities (details)
Organization And Business Operations - Schedule Merger Agreement Based On Common Stock Outstanding (details)
Related Party Transactions
Related Party Transactions (details Narrative)
Stock Incentive Plans
Stock Incentive Plans (details Narrative)
Stock Incentive Plans (tables)
Stock Incentive Plans - Schedule Of Stock Option Activity (details)
Stock Incentive Plans - Schedule Of Summary Of Additional Information On Stock Options Outstanding (details)
Stockholders' Equity
Stockholders' Equity (details Narrative)
Stockholders' Equity (tables)
Stockholders??? Equity - Schedule Of Warrant Activity (details)
Subsequent Events
Subsequent Events (details Narrative)
Material Contracts, Statements, Certifications & more
Adhera Therapeutics, Inc. provided additional information to their SEC Filing as exhibits
CIK: 737207
Form Type: 10-Q Quarterly Report
Accession Number: 0001493152-17-005362
Submitted to the SEC: Mon May 15 2017 5:11:10 PM EST
Accepted by the SEC: Mon May 15 2017
Period: Friday, March 31, 2017
Industry: Pharmaceutical Preparations
External Resources:
SEC.gov
Bookmark the Permalink: https://last10k.com/sec-filings/737207/0001493152-17-005362.htm
SEC Filing Exhibit
PDF Download
Loading SEC Filing Exhibit...
Excel DownloadLoading SEC Filing Financial Summary...